Skip to content
ppharmaranks
Menu
Class IIOngoing

Albuterol Sulfate Inhalation Solution recall

FDA recall D-0479-2026 · initiated Mar 17, 2026

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Apr 22, 2026How we research

Nephron SC, LLC recalled Albuterol Sulfate Inhalation Solution in Mar 2026 — an FDA Class II recall (D-0479-2026) because Labelling: Illegible label.

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

Labelling: Illegible label

Labelling, packaging or a product mix-up

The wrong information — or the wrong medicine — ended up in the pack. A mix-up is a manufacturing failure that can still be dangerous to swallow.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

Lot AB6001, exp date 1/15/2027

Quantity recalled: 146,280 vials

Details

Product
Albuterol Sulfate Inhalation Solution, 0.5%, 25 mg/5 mL (5 mg/mL*), 30x5 mL Sterile Unit-Dose Vials, Rx only, nephron 503B Outsourcing facility, 4600 12th Street Extension, West Columbia, SC 29172, NDC 69374-330-05.
Recalling company
Nephron SC, LLC
Classification
Class II
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
Nationwide within the United States
Initiated
Mar 17, 2026
FDA report date
Apr 22, 2026
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was Albuterol Sulfate Inhalation Solution recalled?
Nephron SC, LLC recalled Albuterol Sulfate Inhalation Solution in Mar 2026 — an FDA Class II recall (D-0479-2026) because Labelling: Illegible label. May cause temporary or medically reversible harm; low probability of serious harm.
Why was Albuterol Sulfate Inhalation Solution recalled?
Per the FDA enforcement record, the reason for recall D-0479-2026 was: Labelling: Illegible label
Is a recalled Albuterol Sulfate Inhalation Solution dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of Albuterol Sulfate Inhalation Solution are affected?
Distributed: Nationwide within the United States. The recall covers these lots — Lot AB6001, exp date 1/15/2027. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0479-2026.

Source: openFDA Drug Enforcement record D-0479-2026

← All drug recalls